← 홈

대장·직결장암

176개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 176개
AntibodystaleBeiGenePhase 2

Tislelizumab combined with chemotherapy (Tislelizumab combined with chemotherapy)

Rectal Cancer; Rectal Cancer Stage II · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleDaping Hospital and the Researc…Phase 2

PCSK9 Inhibitor (Tolecizumab, Tolecizumab (PCSK9 Inhibitor))

Colon Adenocarcinoma · Colon Adenocarcinoma

#ColonAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleChia Tai Tianqing Pharmaceutica…Phase 3

Trifluridine /Tipiracil (TAS-102, Trifluridine /Tipiracil, Trifluridine /Tipiracil (TAS-102) tablets / Fruquintinib / Regorafenib tablets)

HER2 IHC3+ Advanced Colorectal Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Trifluridine-tipiracil plus Bevacizumab Alone (Trifluridine-tipiracil plus Bevacizumab Alone)

Refractory Metastatic Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleM.D. Anderson Cancer CenterPhase 1

TAS-102 (Trifluridine/tipiracil, Trifluridine/tipiracil (TAS-102))

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Trifluridine/tipiracil (TAS-102, Trifluridine/tipiracil, Trifluridine/tipiracil (TAS-102) plus bevacizumab)

Colo-rectal Cancer; Third-line and Beyond Therapy · Colo-rectal Cancer

#Colo-rectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleNational Cancer Institute (NCI)Phase 1

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Ziv-Aflibercept)

Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Colorectal Carcinoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

[225Ac]-FPI-2068 ([225Ac]-FPI-2068)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleIsofol Medical ABPhase 2

ARFOX + bevacizumab (arfolitixorin, arfolitixorin (ARFOX + bevacizumab))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

capecitabine and oxaliplatin + cetuximab (capecitabine and oxaliplatin + cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

fulzerasib; cetuximab N01 (fulzerasib; cetuximab N01)

Colorectal Cancer; KRAS G12C Mutant Advanced Solid Tumors · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleBeijing HospitalPhase 2

irinotecan, cetuximab, envafolimab (irinotecan, cetuximab, envafolimab)

RAS Mutation; Metastatic Colorectal Cancer · RAS Mutation

#RASMutation#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

miFL + bevacizumab (miFL + bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

oxaliplatin+capecitabine+bevacizumab+PD-1 antibody (oxaliplatin+capecitabine+bevacizumab+PD-1 antibody)

Colorectal Cancer; RAS Mutation · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleUniversity of UtahPhase 1

regorafenib + panitumumab (regorafenib + panitumumab)

KRAS and NRAS Wild-type Colorectal Cancer · KRAS and NRAS Wild-type Colorectal Cance

#KRASandNRASWild-typeColorectalCa#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

serplulimab、bevacizumab (serplulimab、bevacizumab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING

9 / 9 페이지

← 이전다음 →